The glucose-dependent insulinotropic polypeptide (GIP), another gastrointestinal hormone, plays a similar role to the GLP-1 hormone, and GIP receptors are another target for weight-loss drugs
Route of administration varies across studiesintraperitoneal injection in rodent models, subcutaneous in larger animals, and oral in gastric protection studies
NAD+ supports sirtuins, which regulate the autophagy program
Alternative commercially available treatments for constipation include osmotic laxatives such as polyethylene glycol (MiraLAX), stimulant laxatives such as bisacodyl (Fleet Stimulant Oral Laxative) and senna, glycerin suppositories (Fleet Liquid Glycerin Suppositories), and enemas
By following the prescribed treatment plan and making healthy lifestyle choices, you can achieve lasting weight loss and enjoy the benefits of improved health